{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T02:30:20Z","timestamp":1780453820316,"version":"3.54.1"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T00:00:00Z","timestamp":1593475200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.01187","type":"journal-article","created":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T04:37:00Z","timestamp":1593491820000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":35,"title":["Bibliometrics Analysis of Butyrophilins as Immune Regulators [1992\u20132019] and Implications for Cancer Prognosis"],"prefix":"10.3389","volume":"11","author":[{"given":"Yixi","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinrong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangzhe","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kebing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhinan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejia","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibo","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongbo","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianlei","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,6,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"399","DOI":"10.5114\/ceji.2017.72806","article-title":"Butyrophilins: an important new element of resistance","volume":"42","author":"Malinowska","year":"2017","journal-title":"Cent Eur J Immunol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1083\/jcb.89.3.485","article-title":"Antibodies to the major insoluble milk fat globule membrane-associated protein: specific location in apical regions of lactating epithelial cells","volume":"89","author":"Franke","year":"1981","journal-title":"J Cell Biol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/0005-2736(83)90476-5","article-title":"Butyrophilin, an apical plasma membrane-associated glycoprotein characteristic of lactating mammary glands of diverse species","volume":"728","author":"Heid","year":"1983","journal-title":"Biochim Biophys Acta."},{"key":"B4","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nri3715","article-title":"Immune modulation by butyrophilins","volume":"14","author":"Arnett","year":"2014","journal-title":"Nat Rev Immunol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/ng1519","article-title":"Sarcoidosis is associated with a truncating splice site mutation in BTNL2","volume":"37","author":"Valentonyte","year":"2005","journal-title":"Nat Genet."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/S0140-6736(97)10322-1","article-title":"Role of human-milk lactadherin in protection against symptomatic rotavirus infection","volume":"351","author":"Newburg","year":"1998","journal-title":"Lancet."},{"key":"B7","doi-asserted-by":"publisher","first-page":"847","DOI":"10.2337\/db18-0882","article-title":"Genetic contribution to the divergence in type 1 diabetes risk between children from the general population and children from affected families","volume":"68","author":"Hippich","year":"2019","journal-title":"Diabetes."},{"key":"B8","doi-asserted-by":"publisher","first-page":"3190","DOI":"10.12659\/MSM.914074","article-title":"Butyrophilin-Like 9 (BTNL9) suppresses invasion and correlates with favorable prognosis of uveal melanoma","volume":"25","author":"Jiang","year":"2019","journal-title":"Med Sci Monit."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1002\/jcb.29485","article-title":"BTN3A2 serves as a prognostic marker and favors immune infiltration in triple-negative breast cancer","volume":"121","author":"Cai","year":"2020","journal-title":"J Cell Biochem."},{"key":"B10","doi-asserted-by":"publisher","first-page":"48460","DOI":"10.18632\/oncotarget.17223","article-title":"Global scientific trends on exosome research during 2007\u20132016: a bibliometric analysis","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1007\/s11695-016-2160-x","article-title":"Publication trends in bariatric surgery: a bibliometric study","volume":"26","author":"Dabi","year":"2016","journal-title":"Obesity Surg."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e0133009","DOI":"10.1371\/journal.pone.0133009","article-title":"Type 2 diabetes research yield, 1951-2012: bibliometrics analysis and density-equalizing mapping","volume":"10","author":"Geaney","year":"2015","journal-title":"PLoS ONE."},{"key":"B13","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.it.2011.09.007","article-title":"Butyrophilins: an emerging family of immune regulators","volume":"33","author":"Abeler-Dorner","year":"2012","journal-title":"Trends Immunol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1146\/annurev-immunol-041015-055435","article-title":"Regulation of immunity by butyrophilins","volume":"34","author":"Rhodes","year":"2016","journal-title":"Annu Rev Immunol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1182\/blood-2012-05-430470","article-title":"Key implication of CD277\/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human \u03b3\u03b4 T-cell subset","volume":"120","author":"Harly","year":"2012","journal-title":"Blood."},{"key":"B16","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.immuni.2019.09.006","article-title":"Butyrophilin-like 3 directly binds a human V\u03b34(+) T cell receptor using a modality distinct from clonally-restricted antigen","volume":"51","author":"Willcox","year":"2019","journal-title":"Immunity."},{"key":"B17","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.cell.2016.08.030","article-title":"Epithelia use butyrophilin-like molecules to shape organ-specific \u03b3\u03b4 T cell compartments","volume":"167","author":"Di Marco Barros","year":"2016","journal-title":"Cell."},{"key":"B18","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/ng.108","article-title":"Skint1, the prototype of a newly identified immunoglobulin superfamily gene cluster, positively selects epidermal \u03b3\u03b4 T cells","volume":"40","author":"Boyden","year":"2008","journal-title":"Nat Genet."},{"key":"B19","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3389\/fimmu.2020.00259","article-title":"Bibliometric analysis of dendritic epidermal T cell (DETC) research from 1983 to 2019","volume":"11","author":"Deng","year":"2020","journal-title":"Front Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1038\/nm.3909","article-title":"The prognostic landscape of genes and infiltrating immune cells across human cancers","volume":"21","author":"Gentles","year":"2015","journal-title":"Nat Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1001\/jamaoncol.2016.5688","article-title":"Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study","volume":"3","author":"Fitzmaurice","year":"2017","journal-title":"JAMA Oncol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J Clin."},{"key":"B23","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature25183","article-title":"The biology and management of non-small cell lung cancer","volume":"553","author":"Herbst","year":"2018","journal-title":"Nature."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1753466618794133","DOI":"10.1177\/1753466618794133","article-title":"New strategies in immunotherapy for lung cancer: beyond PD-1\/PD-L1","volume":"12","author":"Villanueva","year":"2018","journal-title":"Ther Adv Respir Dis."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1016\/S0140-6736(16)00587-0","article-title":"Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial","volume":"387","author":"Fehrenbacher","year":"2016","journal-title":"Lancet."},{"key":"B26","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0140-6736(16)32517-X","article-title":"Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial","volume":"389","author":"Rittmeyer","year":"2017","journal-title":"Lancet."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1001\/jamaoncol.2016.0639","article-title":"Biomarkers for the clinical use of PD-1\/PD-L1 inhibitors in non-small-cell lung cancer: a review","volume":"2","author":"Sacher","year":"2016","journal-title":"JAMA Oncol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"3924","DOI":"10.1200\/JCO.2017.74.3062","article-title":"Nivolumab versus docetaxel in previously treated patients with advanced non-small-cell lung cancer: two-year outcomes from two randomized, open-label, phase III Trials (checkMate 017 and checkMate 057)","volume":"35","author":"Horn","year":"2017","journal-title":"J Clin Oncol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1093\/hmg\/ddw414","article-title":"Association between GWAS-identified lung adenocarcinoma susceptibility loci and EGFR mutations in never-smoking Asian women, and comparison with findings from Western populations","volume":"26","author":"Seow","year":"2017","journal-title":"Hum Mol Genet."},{"key":"B30","doi-asserted-by":"publisher","first-page":"12451","DOI":"10.1038\/ncomms12451","article-title":"Association of variations in HLA class II and other loci with susceptibility to EGFR-mutated lung adenocarcinoma","volume":"7","author":"Shiraishi","year":"2016","journal-title":"Nat Commun."},{"key":"B31","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1038\/ng.2353","article-title":"A genome-wide association study identifies two new susceptibility loci for lung adenocarcinoma in the Japanese population","volume":"44","author":"Shiraishi","year":"2012","journal-title":"Nat Genet."},{"key":"B32","doi-asserted-by":"publisher","first-page":"564","DOI":"10.3389\/fphar.2019.00564","article-title":"Trends in sigma-1 receptor research: a 25-year bibliometric analysis","volume":"10","author":"Romero","year":"2019","journal-title":"Front Pharmacol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1096\/fj.07-9492LSF","article-title":"Comparison of pubmed, scopus, web of science, and google scholar: strengths and weaknesses","volume":"22","author":"Falagas","year":"2008","journal-title":"FASEB J."},{"key":"B34","doi-asserted-by":"publisher","first-page":"296","DOI":"10.4103\/1008-682X.171582","article-title":"Bibliometrics: tracking research impact by selecting the appropriate metrics","volume":"18","author":"Agarwal","year":"2016","journal-title":"Asian J Androl."},{"key":"B35","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/ng0997-25","article-title":"A candidate gene for familial Mediterranean fever","volume":"17","author":"French","year":"1997","journal-title":"Nat Genet."},{"key":"B36","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/nri727","article-title":"The B7-CD28 superfamily","volume":"2","author":"Sharpe","year":"2002","journal-title":"Nat Rev Immunol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/ni.2665","article-title":"Butyrophilin 3A1 binds phosphorylated antigens and stimulates human \u03b3\u03b4 T cells","volume":"14","author":"Vavassori","year":"2013","journal-title":"Nat Immunol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.immuni.2014.03.003","article-title":"The intracellular B30.2 domain of butyrophilin 3A1 binds phosphoantigens to mediate activation of human V\u03b39V\u03b42 T cells","volume":"40","author":"Sandstrom","year":"2014","journal-title":"Immunity."},{"key":"B39","doi-asserted-by":"publisher","first-page":"eaax9364","DOI":"10.1126\/scitranslmed.aax9364","article-title":"An innate-like V\u03b41(+) \u03b3\u03b4 T cell compartment in the human breast is associated with remission in triple-negative breast cancer","volume":"11","author":"Wu","year":"2019","journal-title":"Sci Transl Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1158\/2326-6066.CIR-19-0513","article-title":"\u03b3\u03b4 T-cell receptors derived from breast cancer-infiltrating T lymphocytes mediate antitumor reactivity","volume":"8","author":"Janssen","year":"2020","journal-title":"Cancer Immunol Res."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.immuni.2019.02.016","article-title":"A structural change in Butyrophilin upon phosphoantigen binding underlies phosphoantigen-mediated V\u03b39V\u03b42 T cell activation","volume":"50","author":"Yang","year":"2019","journal-title":"Immunity."},{"key":"B42","doi-asserted-by":"publisher","first-page":"eaay5516","DOI":"10.1126\/science.aay5516","article-title":"Butyrophilin 2A1 is essential for phosphoantigen reactivity by \u03b3\u03b4 T cells","volume":"367","author":"Rigau","year":"2020","journal-title":"Science."},{"key":"B43","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/nri797","article-title":"\u03b3\u03b4 T cells: functional plasticity and heterogeneity","volume":"2","author":"Carding","year":"2002","journal-title":"Nat Rev Immunol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"126","DOI":"10.4049\/jimmunol.0903767","article-title":"Naturally activated V\u03b34 \u03b3\u03b4 T cells play a protective role in tumor immunity through expression of eomesodermin","volume":"185","author":"He","year":"2010","journal-title":"J Immunol."},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-020-0500-9","article-title":"Roles of mTORC1 and mTORC2 in controlling \u03b3\u03b4 T1 and T17 differentiation and function","author":"Yang","year":"2020","journal-title":"Cell Death Differ."},{"key":"B46","doi-asserted-by":"publisher","first-page":"4979","DOI":"10.4049\/jimmunol.1101389","article-title":"Regulatory role of V\u03b31 \u03b3\u03b4 T cells in tumor immunity through IL-4 production","volume":"187","author":"Hao","year":"2011","journal-title":"J Immunol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"5007","DOI":"10.4049\/jimmunol.1101315","article-title":"V\u03b34 \u03b3\u03b4 T cell-derived IL-17A negatively regulates NKT cell function in con A-induced fulminant hepatitis","volume":"187","author":"Zhao","year":"2011","journal-title":"J Immunol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/d41586-018-06751-0","article-title":"Cancer immunologists scoop medicine nobel prize","volume":"562","author":"Ledford","year":"2018","journal-title":"Nature."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01187\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T04:37:04Z","timestamp":1593491824000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01187\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,30]]},"references-count":48,"alternative-id":["10.3389\/fimmu.2020.01187"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.01187","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,30]]},"article-number":"1187"}}